aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.46) per share which met the analyst consensus estimate. This is a 9.52 percent decrease over losses of $(0.42) per share from the same period last year.
UBS Prepping For Massive Layoffs Amid Credit Suisse Takeover: Report
UBS Group AG (NYSE: UBS), which agreed to buy peer Credit Suisse AG (NYSE: CS)